Product
AAV2-hCHM
1 clinical trial
1 indication
Indication
ChoroideremiaClinical trial
A Phase 1/2 Safety Study in Subjects With CHM (Choroideremia) Gene Mutations Using an Adeno-Associated Virus Serotype 2 Vector to Deliver the Normal Human CHM Gene [AAV2-hCHM] to the RetinaStatus: Completed, Estimated PCD: 2022-10-12